Natera Inc. (NTRA)
NASDAQ: NTRA
· Real-Time Price · USD
162.47
-3.13 (-1.89%)
At close: Aug 25, 2025, 3:59 PM
162.70
0.14%
After-hours: Aug 25, 2025, 07:53 PM EDT
-1.89% (1D)
| Bid | 156.5 |
| Market Cap | 22.3B |
| Revenue (ttm) | 1.96B |
| Net Income (ttm) | -253.24M |
| EPS (ttm) | -1.9 |
| PE Ratio (ttm) | -85.51 |
| Forward PE | -165.26 |
| Analyst | Buy |
| Ask | 165 |
| Volume | 1,053,892 |
| Avg. Volume (20D) | 1,403,716 |
| Open | 165.30 |
| Previous Close | 165.60 |
| Day's Range | 161.89 - 168.52 |
| 52-Week Range | 110.57 - 183.00 |
| Beta | 1.76 |
About NTRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NTRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NTRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Natera Inc. is scheduled to release its earnings on
Nov 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+3.35%
Natera shares are trading higher after Piper Sandl...
Unlock content with
Pro Subscription
2 weeks ago
+7.7%
Natera shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY25 sales guidance above estimates.
18 hours ago · businesswire.com
Natera to Present Signatera™ Data at the IASLC World Conference on Lung CancerAUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will present new data at the 2025 International Associatio...
2 weeks ago · fool.com
Natera (NTRA) Q2 Revenue Jumps 32%Natera (NTRA) Q2 Revenue Jumps 32%